- Ex vivo efficacy of anti-cancer drug PNC-27 in the treatment of patient-derived epithelial ovarian cancer. Annals of Clinical and Laboratory Science. 2015 Academic Article GET IT
Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes.
Proceedings of the National Academy of Sciences of the United States of America.
Times cited: 17
The penetratin sequence in the anticancer PNC-28 peptide causes tumor cell necrosis rather than apoptosis of human pancreatic cancer cells.
Annals of Surgical Oncology.
Times cited: 12